The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination
Clinical trial NCT06751251 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06751251
- Sponsor
- Peking University People's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-01
- Primary completion
- 2025-10-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.